The landscape of prognostic and immunological role of myosin light chain 9 (MYL9) in human tumors
ConclusionMYL9 can serve as a prognostic signature in pan-cancer and is associated with immune infiltration. This pan-cancer study is the first to show a relatively comprehensive understanding of the prognostic and immunological roles of MYL9 across different cancers.
Source: Immunity, Inflammation and Disease - Category: Allergy & Immunology Authors: Minghe Lv,
Lumeng Luo,
Xue Chen Tags: SHORT REPORT Source Type: research
More News: Adenocarcinoma | Adrenocortical Carcinoma | Allergy & Immunology | Bile Duct Cancer | Brain | Brain Cancers | Brain Tumor | Breast Cancer | Breast Carcinoma | Cancer | Cancer & Oncology | Carcinoma | Cholangiocarcinoma | Colon Cancer | Colorectal Cancer | Gastric (Stomach) Cancer | Gastroenterology | Genetics | Glioma | Head and Neck Cancer | Hepatocellular Carcinoma | HIV AIDS | HNSCC | Liver | Liver Cancer | Lung Cancer | Neurology | Ovarian Cancer | Ovaries | Prostate Cancer | Skin Cancer | Squamous Cell Carcinoma | Statistics | Study | Urology & Nephrology
MedWorm Privacy Policy
Disclaimer
Copyright © MedWorm 2006-2024